Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6835
Rank
S$0.79 B
Marketcap
S$39.69
Share price
0.43%
Change (1 day)
-15.71%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$65.92 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are S$65.92 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$57.44 M11.33%
2023-12-31S$51.6 M